Skip to main content
. 2019 Jun 6;40(45):3672–3681. doi: 10.1093/eurheartj/ehz396

Table 2.

Genetic characteristics (n = 524)

Variables N Statistics
Paediatric relative with genetic testing
 Subject had genetic testing 524 120 (22.9%)
 Variant identified 120
  No 28 (23.3%)
  Pathogenic 86 (71.7%)
  Variant of uncertain significance 6 (5.0%)
 Affected gene
  MYH7 86 27 (31.4%)
  MYBPC3 86 43 (50.0%)
  PRKAG2 + MYBPC3 86 1 (1.2%)
  TPM1 86 8 (9.3%)
  TNNI/TNNT 86 3 (3.5%)
  MYL2 86 2 (2.4%)
  TMPO 86 1 (1.2%)
  Unknown/Missing 86 1 (1.2%)
Proband with genetic testing
 Variant identified in the proband
  Pathogenic 95 (23.5%)
  Variant of uncertain significance 30 (7.4%)
 Affected gene
  Unknown 95 15 (15.8%)
  MYH7 95 27 (28.4%)
  MYBPC3 95 41 (43.1%)
  TNN13 95 5 (5.3%)
  TPM1 95 4 (4.2%)
  TNNT2 95 2 (2.1%)
  PRKAG2 95 1 (1.1%)